| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.602 | 0.007 | 0.602 | Anticonvulsant | 0.402 0.021 DBMET01680 | ||
| 0.59 | 0.002 | 0.59 | Benzodiazepine agonist | 0.236 0.004 DBMET01680 | ||
| 0.353 | 0.008 | 0.381 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.381 0.006 DBMET01680 | DBMET01680 | |
| 0.349 | 0.005 | 0.349 | GABA receptor agonist | 0.23 0.012 DBMET01680 | ||
| 0.346 | 0.029 | 0.39 | Clk dual-specificity kinase inhibitor | 0.39 0.021 DBMET01680 | DBMET01680 | |
| 0.379 | 0.071 | 0.383 | MAP kinase kinase 6 inhibitor | 0.383 0.069 DBMET01680 | DBMET01680 | |
| 0.308 | 0.004 | 0.308 | GABA A receptor agonist | 0.225 0.008 DBMET01680 | ||
| 0.287 | 0.011 | 0.322 | CDC-like kinase 1 inhibitor | 0.322 0.008 DBMET01680 | DBMET01680 | |
| 0.282 | 0.013 | 0.282 | Interleukin 1 antagonist | 0.277 0.014 DBMET01680 | ||
| 0.3 | 0.032 | 0.322 | CDC-like kinase 4 inhibitor | 0.322 0.027 DBMET01680 | DBMET01680 | |
| 0.294 | 0.055 | 0.361 | Dyrk kinase inhibitor | 0.361 0.034 DBMET01680 | DBMET01680 | |
| 0.283 | 0.055 | 0.36 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.36 0.033 DBMET01680 | DBMET01680 | |
| 0.212 | 0.003 | 0.212 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.19 0.004 DBMET01680 | ||
| 0.238 | 0.05 | 0.278 | CDC-like kinase 2 inhibitor | 0.278 0.037 DBMET01680 | DBMET01680 | |
| 0.23 | 0.056 | 0.298 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.298 0.028 DBMET01680 | DBMET01680 | |
| 0.198 | 0.025 | 0.331 | Protein kinase (CK2) alpha inhibitor | 0.331 0.009 DBMET01680 | DBMET01680 | |
| 0.319 | 0.16 | 0.333 | MAP kinase 1 inhibitor | 0.333 0.148 DBMET01680 | DBMET01680 | |
| 0.191 | 0.037 | 0.205 | Cyclin-dependent kinase 7 inhibitor | 0.205 0.032 DBMET01680 | DBMET01680 | |
| 0.175 | 0.024 | 0.278 | Protein kinase (CK2) inhibitor | 0.278 0.008 DBMET01680 | DBMET01680 | |
| 0.15 | 0.019 | 0.154 | CDC-like kinase 3 inhibitor | 0.154 0.017 DBMET01680 | DBMET01680 | |
| 0.32 | 0.196 | 0.32 | Antiinflammatory | 0.302 0.214 DBMET01680 | ||
| 0.15 | 0.026 | 0.15 | CDK2/cyclin A inhibitor | 0.148 0.027 DBMET01680 | ||
| 0.172 | 0.055 | 0.197 | Cyclooxygenase inhibitor | 0.197 0.043 DBMET01680 | DBMET01680 | |
| 0.121 | 0.012 | 0.121 | GABA A receptor antagonist | |||
| 0.182 | 0.073 | 0.27 | LIM domain kinase 1 inhibitor | 0.27 0.029 DBMET01680 | DBMET01680 | |
| 0.139 | 0.033 | 0.154 | CDK/cyclin complex inhibitor | 0.154 0.028 DBMET01680 | DBMET01680 | |
| 0.184 | 0.084 | 0.184 | Non-steroidal antiinflammatory agent | 0.142 0.127 DBMET01680 | ||
| 0.268 | 0.174 | 0.386 | Transcription factor inhibitor | 0.386 0.115 DBMET01680 | DBMET01680 | |
| 0.156 | 0.063 | 0.156 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.185 | 0.093 | 0.242 | Interleukin antagonist | 0.242 0.065 DBMET01680 | DBMET01680 | |
| 0.116 | 0.027 | 0.131 | MAP kinase 11 inhibitor | 0.131 0.022 DBMET01680 | DBMET01680 | |
| 0.114 | 0.028 | 0.128 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.128 0.021 DBMET01680 | DBMET01680 | |
| 0.145 | 0.06 | 0.162 | Cyclooxygenase 1 inhibitor | 0.162 0.051 DBMET01680 | DBMET01680 | |
| 0.107 | 0.025 | 0.112 | Adenosine A2 receptor antagonist | 0.112 0.024 DBMET01680 | DBMET01680 | |
| 0.21 | 0.131 | 0.21 | Lipoxygenase inhibitor | |||
| 0.238 | 0.159 | 0.238 | Toll-Like receptor 7 agonist | |||
| 0.092 | 0.018 | 0.092 | GABA receptor antagonist | |||
| 0.128 | 0.053 | 0.187 | Cyclin-dependent kinase 5 inhibitor | 0.187 0.026 DBMET01680 | DBMET01680 | |
| 0.154 | 0.083 | 0.182 | Heat shock protein 90 alpha antagonist | 0.182 0.061 DBMET01680 | DBMET01680 | |
| 0.23 | 0.168 | 0.23 | Toll-Like receptor agonist | |||
| 0.205 | 0.145 | 0.205 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.082 | 0.024 | 0.082 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.235 | 0.178 | 0.235 | 15-Lipoxygenase inhibitor | 0.207 0.206 DBMET01680 | ||
| 0.124 | 0.076 | 0.142 | Cyclooxygenase 2 inhibitor | 0.142 0.06 DBMET01680 | DBMET01680 | |
| 0.124 | 0.082 | 0.124 | Toll-Like receptor 9 antagonist | |||
| 0.049 | 0.008 | 0.049 | Bradykinin B2 receptor antagonist | |||
| 0.062 | 0.022 | 0.068 | Adenosine A2b receptor antagonist | 0.068 0.019 DBMET01680 | DBMET01680 | |
| 0.202 | 0.162 | 0.202 | Immunomodulator | |||
| 0.047 | 0.009 | 0.047 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.176 | 0.139 | 0.195 | MAP-kinase-activated kinase 5 inhibitor | 0.195 0.11 DBMET01680 | DBMET01680 | |
| 0.143 | 0.107 | 0.182 | TRKC antagonist | 0.182 0.078 DBMET01680 | DBMET01680 | |
| 0.148 | 0.113 | 0.148 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.106 | 0.073 | 0.12 | Activin receptor-like kinase 4 inhibitor | 0.12 0.052 DBMET01680 | DBMET01680 | |
| 0.071 | 0.038 | 0.083 | MAP kinase kinase 10 inhibitor | 0.083 0.026 DBMET01680 | DBMET01680 | |
| 0.068 | 0.036 | 0.074 | CDK2/cyclin E inhibitor | 0.074 0.033 DBMET01680 | DBMET01680 | |
| 0.159 | 0.128 | 0.179 | Aryl hydrocarbon receptor agonist | 0.179 0.115 DBMET01680 | DBMET01680 | |
| 0.068 | 0.038 | 0.09 | Adenosine A2a receptor antagonist | 0.09 0.028 DBMET01680 | DBMET01680 | |
| 0.059 | 0.033 | 0.085 | MAP kinase kinase 9 inhibitor | 0.085 0.013 DBMET01680 | DBMET01680 | |
| 0.074 | 0.051 | 0.111 | Adenosine A3 receptor antagonist | 0.111 0.021 DBMET01680 | DBMET01680 | |
| 0.06 | 0.038 | 0.06 | CDK4/cyclin D inhibitor | 0.056 0.044 DBMET01680 | ||
| 0.106 | 0.085 | 0.129 | Cyclin-dependent kinase inhibitor | 0.129 0.068 DBMET01680 | DBMET01680 | |
| 0.068 | 0.049 | 0.079 | MAP kinase kinase 8 inhibitor | 0.079 0.036 DBMET01680 | DBMET01680 | |
| 0.091 | 0.073 | 0.114 | Cyclin-dependent kinase 9 inhibitor | 0.114 0.05 DBMET01680 | DBMET01680 | |
| 0.12 | 0.108 | 0.12 | Tyrosine kinase inhibitor | |||
| 0.151 | 0.14 | 0.203 | Growth factor agonist | 0.203 0.06 DBMET01680 | DBMET01680 | |
| 0.077 | 0.069 | 0.111 | Stem cell growth factor agonist | 0.111 0.036 DBMET01680 | DBMET01680 | |
| 0.104 | 0.097 | 0.113 | Tubulin antagonist | 0.113 0.088 DBMET01680 | DBMET01680 | |
| 0.043 | 0.036 | 0.043 | CDK7/cyclin H inhibitor | |||
| 0.037 | 0.03 | 0.057 | MAP3K5 inhibitor | 0.057 0.007 DBMET01680 | DBMET01680 | |
| 0.056 | 0.05 | 0.057 | CDK1/cyclin B inhibitor | 0.057 0.05 DBMET01680 | DBMET01680 | |
| 0.139 | 0.135 | 0.191 | Death-associated protein kinase 2 inhibitor | 0.191 0.042 DBMET01680 | DBMET01680 | |
| 0.086 | 0.083 | 0.086 | Insulin receptor antagonist | |||
| 0.043 | 0.043 | 0.044 | Benzodiazepine inverse agonist | 0.044 0.039 DBMET01680 | DBMET01680 | |
| 0.084 | 0.087 | 0.093 | Alpha 2d adrenoreceptor antagonist | 0.093 0.063 DBMET01680 | DBMET01680 | |
| 0.082 | 0.087 | 0.102 | MAP kinase 8 inhibitor | 0.102 0.058 DBMET01680 | DBMET01680 | |
| 0.024 | 0.031 | 0.026 | Glucosylceramidase stimulant | 0.026 0.025 DBMET01680 | DBMET01680 | |
| 0.063 | 0.075 | 0.078 | MAP kinase 10 inhibitor | 0.078 0.054 DBMET01680 | DBMET01680 | |
| 0.137 | 0.151 | 0.173 | Focal adhesion kinase 2 inhibitor | 0.173 0.096 DBMET01680 | DBMET01680 | |
| 0.043 | 0.061 | 0.051 | CDK9/cyclin T1 inhibitor | 0.051 0.05 DBMET01680 | DBMET01680 | |
| 0.082 | 0.101 | 0.102 | Glycogen synthase kinase-3 beta inhibitor | 0.102 0.076 DBMET01680 | DBMET01680 | |
| 0.016 | 0.039 | 0.046 | Cyclin E2 inhibitor | 0.046 0.01 DBMET01680 | DBMET01680 | |
| 0.072 | 0.096 | 0.098 | MAP kinase 9 inhibitor | 0.098 0.064 DBMET01680 | DBMET01680 | |
| 0.05 | 0.077 | 0.08 | MAP kinase 14 inhibitor | 0.08 0.047 DBMET01680 | DBMET01680 | |
| 0.128 | 0.16 | 0.148 | Death-associated protein kinase 3 inhibitor | 0.148 0.125 DBMET01680 | DBMET01680 | |
| 0.075 | 0.109 | 0.101 | Glycogen synthase kinase-3 inhibitor | 0.101 0.078 DBMET01680 | DBMET01680 | |
| 0.075 | 0.112 | 0.105 | Cyclin-dependent kinase 2 inhibitor | 0.105 0.064 DBMET01680 | DBMET01680 | |
| 0.084 | 0.126 | 0.16 | Glycogen synthase kinase-3 alpha inhibitor | 0.16 0.059 DBMET01680 | DBMET01680 | |
| 0.093 | 0.14 | 0.135 | Protein kinase (CK1) gamma 1 inhibitor | 0.135 0.082 DBMET01680 | DBMET01680 | |
| 0.029 | 0.078 | 0.074 | Cyclin E inhibitor | 0.074 0.034 DBMET01680 | DBMET01680 | |
| 0.057 | 0.106 | 0.087 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.087 0.065 DBMET01680 | DBMET01680 | |
| 0.08 | 0.13 | 0.109 | Protein kinase (CK1) inhibitor | 0.109 0.101 DBMET01680 | DBMET01680 | |
| 0.101 | 0.155 | 0.127 | Cyclin-dependent kinase 8 inhibitor | 0.127 0.107 DBMET01680 | DBMET01680 | |
| 0.107 | 0.166 | 0.14 | Death-associated protein kinase 1 inhibitor | 0.14 0.057 DBMET01680 | DBMET01680 | |
| 0.134 | 0.194 | 0.182 | Streptokinase A inhibitor | 0.182 0.145 DBMET01680 | DBMET01680 | |
| 0.097 | 0.166 | 0.131 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.131 0.113 DBMET01680 | DBMET01680 | |
| 0.019 | 0.095 | 0.043 | Cyclin E1 inhibitor | 0.043 0.042 DBMET01680 | DBMET01680 | |
| 0.05 | 0.128 | 0.077 | I kappa B kinase inhibitor | 0.077 0.066 DBMET01680 | DBMET01680 | |
| 0.151 | 0.235 | 0.185 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.185 0.176 DBMET01680 | DBMET01680 | |
| 0.065 | 0.159 | 0.1 | TRKA antagonist | 0.1 0.089 DBMET01680 | DBMET01680 | |
| 0.066 | 0.172 | 0.141 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.141 0.084 DBMET01680 | DBMET01680 | |
| 0.132 | 0.243 | 0.221 | Beta lactamase inhibitor | 0.221 0.172 DBMET01680 | DBMET01680 | |
| 0.033 | 0.156 | 0.064 | I kappa B kinase 2 inhibitor | 0.064 0.04 DBMET01680 | DBMET01680 | |
| 0.065 | 0.216 | 0.112 | CDK3/cyclin E inhibitor | 0.112 0.066 DBMET01680 | DBMET01680 | |
| 0.137 | 0.288 | 0.307 | DNA polymerase beta inhibitor | 0.307 0.162 DBMET01680 | DBMET01680 | |
| 0.075 | 0.234 | 0.165 | Hexokinase inhibitor | 0.165 0.062 DBMET01680 | DBMET01680 | |
| 0.11 | 0.3 | 0.191 | Transcription factor STAT3 inhibitor | 0.191 0.146 DBMET01680 | DBMET01680 | |
| 0.045 | 0.244 | 0.106 | M17 leucyl aminopeptidase inhibitor | 0.106 0.094 DBMET01680 | DBMET01680 | |
| 0.101 | 0.306 | 0.137 | Cyclin-dependent kinase 3 inhibitor | 0.137 0.131 DBMET01680 | DBMET01680 | |
| 0.077 | 0.298 | 0.139 | 3C-like protease (Human coronavirus) inhibitor | 0.139 0.121 DBMET01680 | DBMET01680 | |
| 0.155 | 0.396 | 0.268 | 5 Hydroxytryptamine release inhibitor | 0.268 0.204 DBMET01680 | DBMET01680 | |
| 0.084 | 0.374 | 0.219 | DNA directed DNA polymerase inhibitor | 0.219 0.213 DBMET01680 | DBMET01680 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |